Ralph Bradshaw

Ralph A. Bradshaw earned degrees in chemistry and biochemistry from Colby College (1962) and Duke University (1966), respectively, and received additional research training at Indiana University and the University of Washington. He served on the faculties of Washington University School of Medicine, St. Louis (1969-82) and the Irvine (1982-2006) and San Francisco (2006-2015) campuses of the University of California. He is presently professor in the Dept of Pharmacology, UC San Diego. From 1982 to 1993, he was chair of the Dept. of Biological Chemistry at UCI. He has served as president of the Federation of American Societies for Experimental Biology (FASEB) (1995-96), treasurer of the American Society for Biochemistry and Molecular Biology (1991-97) and was the founding president of the Protein Society (1986-87). He has also been Editor-in-Chief/Associate Editor of several journals (TIBS, Protein Science and the Journal of Biological Chemistry) and in 2000, he founded Molecular and Cellular Proteomics, serving as the Editor until 2013. Among other honors, he received the Passano Foundation Young Scientist Award (1976), the gold medal of the Italian National Research Council (CNR) (1986), the Australian Society of Medical Research Gold Medal (1999) and the HUPO Distinguished Accomplishment in Proteomics Award (2016). He has founded four biotechnology companies (Cortex, EB Technologies, Cavtherx and Trefoil Therapeutics). His research interests have centered on the structure and function of proteins, with much of it focused on polypeptide growth factors, their receptors and the intracellular signals they induce.

Ralph Bradshaw is the Chief Scientific Officer at Trefoil Therapeutics. With a background in Biotechnology, Ralph Bradshaw has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.